The fight against tuberculosis (TB) is getting an upgrade. Traditional treatments rely on
antibiotics but limitations like lengthy regimens and growing drug resistance are pushing
research towards a new frontier: the human body's defenses.This innovative approach focuses on
empowering our immune system to take down TB. By stimulating immune cells researchers aim to
equip them to effectively target and eliminate infected bacteria. Vaccines are under
development to prime the immune system for a stronger response while immunomodulatory drugs
are being investigated to enhance the body's natural TB control mechanisms.This shift in
strategy holds promise for a more effective and streamlined treatment. Shorter durations
reduced risk of resistance and potentially fewer side effects could revolutionize TB
management. This exciting new direction represents a significant step forward in controlling
this global health threat
